Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Cronkhite-Canada syndrome can be diagnosed without gastrointestinal polyps if there is severe mucosal atrophy and edema.

Jarilla-Coffea extract gel effectively and safely increases eyelash and eyebrow thickness in women.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Both mouse and rat models are effective for testing alopecia areata treatments.

The Biofield Energy Treated herbal mixture increased hair growth in mice compared to the untreated mixture.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

Immune cells affect hair growth and could lead to new hair loss treatments.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.